Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|December 29, 2023
Tumour microenvironment influences response to treatment in oesophageal adenocarcinomaClemence J Belle, James M Lonie, Sandra Brosda, et al.
Plos One|May 15, 2020
Impact of fruit orientation and pelleting material on water uptake and germination performance in artificial substrate for sugar beetSebastian Blunk, Jeroen Hoffer, Sandra Brosda, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|February 14, 2026
Agent-MIRA: AI-orchestrated medical imaging agent for PET image retrieval and assistanceRajat Vashistha, Sandra Brosda, Lauren G Aoude, et al.
Annals of Surgery|July 19, 2016
Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open SurgeryAndrew P Barbour, Orla M Mc Cormack, Peter J Baker, et al.
Frontiers in Immunology|November 15, 2023
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobankJames M Lonie, Sandra Brosda, Vanessa F Bonazzi, et al.
Genome Medicine|July 17, 2024
Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapySandra Brosda, Lauren G Aoude, Vanessa F Bonazzi, et al.
Asia-Pacific Journal of Clinical Oncology|July 7, 2023
C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patientsVanessa F Bonazzi, Lauren G Aoude, Sandra Brosda, et al.
Annals of Surgical Oncology|April 4, 2019
The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction AdenocarcinomaSander J M van Hootegem, B Mark Smithers, David C Gotley, et al.
The Journal of Molecular Diagnostics : JMD|August 6, 2023
Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative MelanomaLauren G Aoude, Sandra Brosda, Jessica Ng, et al.
Scientific Reports|October 20, 2020
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patientsLauren G Aoude, Vanessa F Bonazzi, Sandra Brosda, et al.
Pageof 2